AU Stock MarketDetailed Quotes

MSB Mesoblast Ltd

Watchlist
  • 2.370
  • +0.070+3.04%
20min DelayMarket Closed Mar 5 16:00 AET
3.02BMarket Cap-0.18P/E (Static)

Mesoblast Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mesoblast Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 17.569M--
--2025/Q3-- / 7.481M--
Feb 27, 20252025/Q2-- / 2.489M--
--2025/Q1-- / 2.385M--
Aug 29, 20242024/Q4-- / 6.612M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 17.569M--
--2025/Q3-- / 7.481M--
Feb 27, 20252025/Q2-- / 2.489M--
--2025/Q1-- / 2.385M--
Aug 29, 20242024/Q4-- / 6.612M--

Unlock Free Earnings Estimates

Mesoblast Ltd Earnings Reports

  • Mesoblast Ltd: Corporate Presentation and Half Year Financial Results

    Feb 26 16:40 ET

  • Mesoblast Ltd: Half Year Report and Accounts (including Appendix 4D)

    Feb 26 16:37 ET

  • Mesoblast Ltd: Annual Report to Shareholders

    Oct 16, 2024 22:29 ET

  • Mesoblast Ltd: Annual Financial Results Presentation

    Aug 28, 2024 18:13 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Telstra Group Ltd
    TLS
    4.15% 0.18
    BHP Group Ltd
    BHP
    6.03% 2.39
    Origin Energy Ltd
    ORG
    4.50% 0.48
    Rio Tinto Ltd
    RIO
    5.94% 6.98
    ANZ Group Holdings Ltd
    ANZ
    6.04% 1.77

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      0.00%

    • Hold

      25.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday-0.33%